BeiGene, Ltd. (NASDAQ: ONC) reported Q2 EPS of $0.17, $0.04 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.24 billion.

GUIDANCE:

BeiGene, Ltd. sees Q3 2025 revenue of $5-5.3 billion, versus the consensus of $5.132 billion.

For earnings history and earnings-related data on BeiGene, Ltd. (ONC) click here.